About GRS Pharmaceuticals Private Limited
Data last updated:
GRS Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Genethics Regulatory Services Limited. It operates in the application development and software solutions segment of the technology and IT services sector. It was incorporated on 06 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2009PTC194699. Its GSTIN is 27AADCG5160H1ZO (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilesh Prataprai Mehta and Satish Ashtamkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 519 5th Floor Tulsiani Chambers Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.64 Cr. For the same year it recorded a net profit of ₹19.6 Lakh (net margin 7.4%) and EBITDA of ₹29.57 Lakh (EBITDA margin 11.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address519 5th Floor Tulsiani Chambers Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryInformation Technology, Application Development & Software Solutions
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of GRS Pharmaceuticals Private Limited
The main business activity of GRS Pharmaceuticals is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of GRS Pharmaceuticals Private Limited FY 2025 filings available
GRS Pharmaceuticals Private Limited reported revenue of ₹2.64 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR) of GRS Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of GRS Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.57 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of GRS Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of GRS Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Pharmaceuticals, Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abotts Consulting India Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Chennai, Tamil Nadu, India |
| Patron Landmark Project Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Kolkata, West Bengal, India |
| Survisha Technologies Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Bangalore, Karnataka, India |
| D V Properties Pvt Ltd | ₹2.65 Cr (FY 2024) | •••• | •••• | -50.0% | •••• | Surat, Gujarat, India |
| Floradesign India Private Limited | ₹2.65 Cr (FY 2024) | •••• | •••• | 69.0% | •••• | Bangalore, Karnataka, India |
| GRS Pharmaceuticals Private Limited this company | ₹2.64 Cr (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| A A A M Corporate Advisors Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Dadri, Uttar Pradesh, India |
| Arun Tech Industrial Services Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Chennai, Tamil Nadu, India |
| Aqua Lab All Building Material Testing Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Thane, Maharashtra, India |
| Chartered Market Technician Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Cybermate Forensics and Data Security Solutions Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below GRS Pharmaceuticals by revenue in the Consumer Services industry (Pharmaceuticals, Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals Private Limited is audited by SWETA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SWETA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Prataprai Mehta | Director | 24 Mar 2011 | 15 Years 6 Months | Current |
| Satish Ashtamkar | Director | 04 Mar 2023 | 3 Years 7 Months | Current |
Ownership and Shareholding of GRS Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at GRS Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to GRS Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Nimisha Paresh Shah ceased to be Director on 04 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for GRS Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by GRS Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of GRS Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCG5160H1ZO | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of GRS Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GRS Pharmaceuticals Private Limited
GRS Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in application development and software solutions, within the information technology industry. It was incorporated on 06 August 2009 (17+ years old) and is registered under CIN U24110MH2009PTC194699.
GRS Pharmaceuticals reported revenue of ₹2.64 Cr for FY 2024.
GRS Pharmaceuticals has 2 current directors:
- Nilesh Prataprai Mehta - Director
- Satish Ashtamkar - Director
GRS Pharmaceuticals reported a net profit of ₹19.6 Lakh (net margin 7.4%) and EBITDA of ₹29.57 Lakh (EBITDA margin 11.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of GRS Pharmaceuticals is -4% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of GRS Pharmaceuticals is 27AADCG5160H1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of GRS Pharmaceuticals is U24110MH2009PTC194699. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GRS Pharmaceuticals was incorporated on 06 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of GRS Pharmaceuticals by revenue are Abotts Consulting India Private Limited, Patron Landmark Project Private Limited, Survisha Technologies Private Limited, D V Properties Pvt Ltd, Floradesign India Private Limited and 5 more, all in the Consumer Services industry (Pharmaceuticals, Professional Services).
Nimisha Paresh Shah ceased to be Director on 04 Mar 2023. Paresh Pannalal Shah ceased to be Director on 04 Mar 2023. Satish Ashtamkar was appointed as Director on 04 Mar 2023. GRS Pharmaceuticals has 5 board changes on record in total.
GRS Pharmaceuticals can be reached through the website grspharma.com. Its registered office is in Mumbai, Maharashtra, India.